These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22448484)

  • 1. [Nebido in the treatment of hypogonadism syndrome and its complications in men].
    Dedov II; Kurbatov DG; Rozhivanov RV; Lepetukhin AE; Dubskiĭ SA; Goncharov NP
    Urologiia; 2011; (6):59-60, 62-7. PubMed ID: 22448484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of testosterone undecanoate (Nebido(®)) in testosterone deficiency syndrome in Korean: a multicenter prospective study.
    Moon DG; Park MG; Lee SW; Park K; Park JK; Kim SW; Park NC; Ahn TY; Paick JS; Seo JT; Yang DY; Lee JY; Kim JJ
    J Sex Med; 2010 Jun; 7(6):2253-2260. PubMed ID: 20345732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone undecanoate restores erectile function in a subset of patients with venous leakage: a series of case reports.
    Yassin AA; Saad F; Traish A
    J Sex Med; 2006 Jul; 3(4):727-735. PubMed ID: 16839330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
    Morrison BF; Reid M; Madden W; Burnett AL
    Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of testosterone on erectile function: implications for the therapy of erectile dysfunction.
    Saad F; Grahl AS; Aversa A; Yassin AA; Kadioglu A; Moncada I; Eardley I
    BJU Int; 2007 May; 99(5):988-92. PubMed ID: 17309554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone improves erectile function in hypogonadal patients with venous leakage.
    Kurbatov D; Kuznetsky J; Traish A
    J Androl; 2008; 29(6):630-7. PubMed ID: 18599885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study.
    Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
    Andrology; 2017 Sep; 5(5):905-913. PubMed ID: 28771964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome.
    Giltay EJ; Tishova YA; Mskhalaya GJ; Gooren LJ; Saad F; Kalinchenko SY
    J Sex Med; 2010 Jul; 7(7):2572-82. PubMed ID: 20524974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men.
    Zitzmann M; Mattern A; Hanisch J; Gooren L; Jones H; Maggi M
    J Sex Med; 2013 Feb; 10(2):579-88. PubMed ID: 22812645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
    Yassin DJ; Doros G; Hammerer PG; Yassin AA
    J Sex Med; 2014 Jun; 11(6):1567-76. PubMed ID: 24712761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Testosterone Therapy Improves Urinary and Sexual Function, and Quality of Life in Men with Hypogonadism: Results from a Propensity Matched Subgroup of a Controlled Registry Study.
    Haider KS; Haider A; Doros G; Traish A
    J Urol; 2018 Jan; 199(1):257-265. PubMed ID: 28728990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled study.
    Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
    BJU Int; 2016 Nov; 118(5):804-813. PubMed ID: 27124889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone.
    Reyes-Vallejo L; Lazarou S; Morgentaler A
    J Sex Med; 2007 Nov; 4(6):1757-62. PubMed ID: 17087806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone undecanoate improves erectile dysfunction in hypogonadal men with the metabolic syndrome refractory to treatment with phosphodiesterase type 5 inhibitors alone.
    Garcia JA; Sanchez PE; Fraile C; Escovar P
    Andrologia; 2011 Oct; 43(5):293-6. PubMed ID: 21919947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen replacement in men with hypogonadism and erectile dysfunction.
    Albrecht-Betancourt M; Hijazi RA; Cunningham GR
    Endocrine; 2004; 23(2-3):143-8. PubMed ID: 15146093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations.
    Morales A; Black AM; Emerson LE
    BJU Int; 2009 Jan; 103(1):62-4. PubMed ID: 18671790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints.
    Permpongkosol S; Tantirangsee N; Ratana-olarn K
    J Sex Med; 2010 Nov; 7(11):3765-74. PubMed ID: 20807330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only.
    Yassin AA; Saad F
    J Sex Med; 2007 Mar; 4(2):497-501. PubMed ID: 17367445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolving role of testosterone in the treatment of erectile dysfunction.
    Shabsigh R; Rajfer J; Aversa A; Traish AM; Yassin A; Kalinchenko SY; Buvat J
    Int J Clin Pract; 2006 Sep; 60(9):1087-92. PubMed ID: 16939550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypogonadism and cardiovascular diseases in men].
    Ter Arkh; 2011; 83(10):61-7. PubMed ID: 22185029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.